Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Hot Flashes 1

Interventions

Gabapentin 3liposomal amphotericin B 2oxybutynin 1fezolinetant 1black cohosh root extract 1Venlafaxine Hydrochloride 1Vancomycin 1Testosterone 1Tazobactam 1Tamoxifen 1Tablets 1Sugars 1Soybean Proteins 1Pregabalin 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Mind-Body Therapies 1Megestrol Acetate 1Medroxyprogesterone 1Linseed Oil 1Levofloxacin 1Isoflavones 1Hypnosis 1Goserelin 1Folic Acid 1Filgrastim 1Estrogens, Conjugated (USP) 1Estradiol 1Cyproterone Acetate 1Citalopram 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hot Flashes × fezolinetant × Clear all
NCT06440967 2026-04-06

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

Astellas Pharma Inc

Phase 3 Active not recruiting
984 enrolled

Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡